Company Profile
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s lead clinical program is EB-101, its investigational autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa in Phase 3 development. The Company’s development portfolio also features AAV-based gene therapies for ophthalmic diseases with high unmet medical need.
Latest Presentation
Contact Information
Investor Relations
ir@abeonatherapeutics.com
Company Contact
Abeona Therapeutics Inc.
6555 Carnegie Avenue
4th Floor
Cleveland, OH 44103